JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1909 BIX 01294
2 Citation

Target: G9a

Summary: G9a and GLP inhibitor

≥24.45 mg/mL
A1913 RG 108
3 Citation

Target: DNA Methyltransferases

Summary: DNA methyltransferase inhibitor

insoluble in H2O; ≥16.7 mg/mL
A4316 Ketoconazole

Target: Cytochrome P450 (CYP450)

Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase

≥23.4 mg/mL
A4322 Clarithromycin

Target: Cytochrome P450 (CYP450)

Summary: CYP3A inhibitor, potent

≥31.2 mg/mL
A4333 CPI-613
1 Citation

Target: Pyruvate dehydrogenases (PDH)

Summary: PDH/α-KGDH inhibitor

insoluble in H2O; ≥19.45 mg/mL
A4335 Mildronate

Target: Hydroxylases|carnitine reabsorption

Summary: GBB hydroxylase inhibitor
A4353 Pyrimethamine

Summary: DHFR inhibitor

insoluble in H2O; ≥10 mg/mL
A4360 Topiramate

Summary: GluR5 receptor antagonist,anticonvulsant

≥16.95 mg/mL
A4367 Atorvastatin Calcium

Target: HMG-CoA Reductases

Summary: HMG-CoA reductase inhibitor

≥57.75 mg/mL
A4374 PF-3845
1 Citation

Target: FAAH

Summary: FAAH ihibitor,highly potent and selective

≥55.6 mg/mL